Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joël Ménard

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Molecular and Cellular Endocrinology|May 12, 2004
The 45-year story of the development of an anti-aldosterone more specific than spironolactoneJoël Ménard
Presse Medicale (Paris, France : 1983)|July 17, 2004
[What progress can be expected in the management of hypertension? Forecast from 1974 to 2034]Joël Ménard
Bulletin De L'Academie Nationale De Medecine|December 14, 2004
[Is hypertension a disease of the intra-renal renin-angiotensin system?]Joël Ménard
Journal of Hypertension|May 11, 2006
Can the dextroenantiomer of the aromatase inhibitor fadrozole be useful for clinical investigation of aldosterone-synthase inhibition?Joël Ménard, Leigh Pascoe
Hypertension (Dallas, Tex. : 1979)|September 1, 2020
Trends in Worldwide Research in Hypertension Over the Period 1999-2018: A Bibliometric StudyPatrick Devos, Joël Ménard
La Revue Du Praticien|December 5, 2018
Birth of evidence-based medicineJoël Ménard, Pierre Durieux
Medecine Sciences : M/S|October 10, 2006
[Differences and similarities of industrial and institutional promotions]Joël Ménard, Véronique Daurat
Cardiovascular Drugs and Therapy|March 7, 2012
Renin inhibitors and cardiovascular and renal protection: an endless quest?Michel Azizi, Joël Ménard
Presse Medicale (Paris, France : 1983)|January 23, 2016
[Measure of plan Azheimer's impact on the university hospitals articles production through SIGAPS data]Patrick Devos, Antoine Cortot, Joël Ménard
Therapie|August 13, 2009
Relevance of the evaluation criteria used in clinical trials for Alzheimer's diseasePhilippe Truffinet, Régis Bordet, Joël Ménard
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Molecular and Cellular Endocrinology|May 12, 2004
The 45-year story of the development of an anti-aldosterone more specific than spironolactoneJoël Ménard
Presse Medicale (Paris, France : 1983)|July 17, 2004
[What progress can be expected in the management of hypertension? Forecast from 1974 to 2034]Joël Ménard
Bulletin De L'Academie Nationale De Medecine|December 14, 2004
[Is hypertension a disease of the intra-renal renin-angiotensin system?]Joël Ménard
Journal of Hypertension|May 11, 2006
Can the dextroenantiomer of the aromatase inhibitor fadrozole be useful for clinical investigation of aldosterone-synthase inhibition?Joël Ménard, Leigh Pascoe
Hypertension (Dallas, Tex. : 1979)|September 1, 2020
Trends in Worldwide Research in Hypertension Over the Period 1999-2018: A Bibliometric StudyPatrick Devos, Joël Ménard
La Revue Du Praticien|December 5, 2018
Birth of evidence-based medicineJoël Ménard, Pierre Durieux
Medecine Sciences : M/S|October 10, 2006
[Differences and similarities of industrial and institutional promotions]Joël Ménard, Véronique Daurat
Cardiovascular Drugs and Therapy|March 7, 2012
Renin inhibitors and cardiovascular and renal protection: an endless quest?Michel Azizi, Joël Ménard
Presse Medicale (Paris, France : 1983)|January 23, 2016
[Measure of plan Azheimer's impact on the university hospitals articles production through SIGAPS data]Patrick Devos, Antoine Cortot, Joël Ménard
Therapie|August 13, 2009
Relevance of the evaluation criteria used in clinical trials for Alzheimer's diseasePhilippe Truffinet, Régis Bordet, Joël Ménard
Pageof 6